Evolent Health, Inc.
EVH · XNYSCIK 1628908fmd_14RNH2YW8JNHEG1FED5GKGQGY6Services · Services-Management ServicesTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 254 | 435 | 627 | 687 | 925 | 908 | 1,352 | 1,964 | 2,555 | 1,876 |
| Net interest income | 1 | – | – | – | – | – | – | – | – | – |
| Cost of revenue | – | – | – | – | – | 658 | 1,035 | 1,503 | 2,187 | 1,476 |
| Gross profit | – | – | – | – | – | 250 | 317 | 460 | 367 | 400 |
| Research and development | 11 | 17 | 18 | 20 | 15 | 16 | – | – | – | – |
| Selling, general and administrative | 161 | 206 | 235 | 236 | 210 | 219 | 269 | 358 | 263 | 304 |
| Total operating expenses | 492 | 508 | 675 | 996 | 1,192 | 950 | – | – | – | – |
| Operating income | (237) | (73) | (47) | (309) | (263) | (42) | 4 | (71) | (40) | (410) |
| Interest expense | 0 | 4 | 5 | 15 | 28 | 25 | 16 | 54 | 25 | 57 |
| Interest and investment income | 1 | 2 | 3 | 3 | 3 | 0 | 1 | 5 | 6 | 4 |
| Other non-operating income (expense) | 0 | 0 | 0 | (0) | (0) | (0) | 0 | (1) | 0 | 0 |
| Income before taxes | (238) | (76) | (54) | (330) | (331) | (30) | (62) | (202) | (63) | (535) |
| Income tax expense | (11) | (7) | 0 | (23) | (2) | 0 | (43) | (89) | (1) | (0) |
| Net income from continuing operations | (227) | (70) | (54) | (307) | (328) | (30) | (19) | (113) | (62) | (535) |
| Net income | (160) | (61) | (53) | (302) | (334) | (38) | (19) | (113) | (62) | (535) |
| Net income to common shareholders | (160) | (61) | (53) | (302) | (334) | (38) | (19) | (142) | (93) | (579) |